Random triples
| Subject | Object |
|---|---|
| gptkb:MGL-202 | Phase 2 |
| gptkb:Cansino_Biologics_Inc. | Phase III trials |
| gptkb:Karyopharm_Therapeutics_Inc. | Phase 1, Phase 2, Phase 3 |
| gptkb:ALX-0734 | Phase 2 |
| gptkb:Immunomedics,_Inc. | Phase 1 |
| gptkb:Immunomedics,_Inc. | Phase 3 |
| gptkb:Can_Sino_Biologics | Phase III |
| gptkb:Atea_Pharmaceuticals | Phase 2 |
| gptkb:SYN-004 | Phase 1 |
| gptkb:Zymeworks_Canada,_Inc. | Various phases of clinical trials. |
| gptkb:Immunomedics,_Inc. | Phase 2 |
| gptkb:Moderna | Phase 3 trials |
| gptkb:Eiger_Group | Phase 2 and Phase 3 trials |